scholarly journals Viral Load, Integration and Methylation of E2BS3 and 4 in Human Papilloma Virus (HPV) 16-Positive Vaginal and Vulvar Carcinomas

PLoS ONE ◽  
2014 ◽  
Vol 9 (11) ◽  
pp. e112839 ◽  
Author(s):  
Gabriella Lillsunde Larsson ◽  
Gisela Helenius ◽  
Bengt Sorbe ◽  
Mats G. Karlsson
2009 ◽  
Vol 19 (9) ◽  
pp. 1642-1648 ◽  
Author(s):  
Archna Singh ◽  
Palika Datta ◽  
Sunesh Kumar Jain ◽  
Neeraja Bhatla ◽  
Siddhartha Dutta Gupta ◽  
...  

A study of human papilloma virus (HPV) types and variants is important for developing preventive protocols and appropriate intervention targets. The presence of HPV types, their variants, and viral load in a population subset from North India was studied. Polymerase chain reaction (PCR) and line blots were used for HPV genotyping; HPV 16 and 18 viral loads were measured using real-time PCR. Variant analysis was done by sequencing of the PCR-amplified E6/E7regions of HPV 16 and the long control region and E6/E7 regions of HPV 18. The 93.6%, 78.6%, and 10% of tumors, squamous intraepithelial lesions (SILs), and controls were HPV-positive, respectively. The most commonly observed type was HPV 16. Human papilloma virus 73 which is uncommonly observed was seen in 2 tumors. Multiple infections were more common in controls and SILs than tumors. The majority (86.4%) of the HPV 16-positive and all of the HPV 18-positive samples belonged to the European variant class. Five novel nonsynonymous changes were seen in the HPV 16-positive and 2 in HPV 18-positive samples. There was a significant increase in viral loads from controls through SILs to tumors, but no significant differences in viral loads were observed between different stages of cancer. In tumors, a significant increase in HPV 16 viral loads was seen with increasing age. The study shows a similar HPV type and variant distribution to European studies, with some differences in type distribution. Viral load does not appear to be good marker for stage wise progression and intralesional variability may affect its use as a differentiating parameter between high-grade squamous intraepithelial lesion and low-grade squamous intraepithelial lesions.


2019 ◽  
Vol 139 (9) ◽  
pp. S224
Author(s):  
M. Viguier ◽  
B. Poirier ◽  
C. Pérals ◽  
H. Bachelez ◽  
M. Battistella ◽  
...  

The Lancet ◽  
2000 ◽  
Vol 355 (9222) ◽  
pp. 2189-2193 ◽  
Author(s):  
Agnetha M Josefsson ◽  
Patrik KE Magnusson ◽  
Nathalie Ylitalo ◽  
Per Sørensen ◽  
Pernilla Qwarforth-Tubbin ◽  
...  

2013 ◽  
Vol 129 (2) ◽  
pp. 406-411 ◽  
Author(s):  
Gabriella Lillsunde Larsson ◽  
Gisela Helenius ◽  
Sören Andersson ◽  
Bengt Sorbe ◽  
Mats G. Karlsson

2009 ◽  
Vol 46 ◽  
pp. S54
Author(s):  
G. Sourvinos ◽  
I. Mammas ◽  
P. Giamarellou ◽  
C. Michael ◽  
D.A. Spandidos

Author(s):  
Rahul Kumar ◽  
Vinita Trivedi ◽  
Richa Chauhan ◽  
Akhtar Parwez ◽  
Biplab Pal ◽  
...  

There is high incidence of cervical cancer in Bihar, India. Vaccination for cervical cancer in developed countries has played a crucial role in limiting the incidence rate of cervical cancer worldwide. In consideration of debate on clinical efficacy of Human Papilloma Virus (HPV) vaccine in India, study on the prevalence of high risk HPV 16/18 strains in different regions of the nation becomes very crucial. Few individual states have started vaccination but centralised vaccination program does not exist due to lack of sufficient genotypic study of Human Papilloma Virus in different parts of India. Bihar is the third most populous state of India and HPV 16/18 distribution has not been reported yet. The nationwide data of HPV 16/18will help to develop a unified centralised vaccination program. We carried out a distribution study of high risk HPV type 16 and 18 in cervical cancer patients attending a tertiary care hospital of Bihar, India.HPV 16/18 types were analysed in cervical cancer tissues (n = 96) of patients attending the regional cancer hospital of Bihar. Tissue samples were analysed for HPV 16 and HPV 18 using a Real Time PCR technique. The results suggest very high prevalence of HPV 16/18. HPV was identified in all the samples (96/96). About, 74 (77.08%) samples presented with HPV 16 whereas, 16 (16.67%) of the samples presented with HPV 18. 6 Co-infection was presented in 6 (6.25%) of the samples of cervical cancer tissues. HPV 16/18 prevalence is more in the women aged between 41 to 61 years.We report 100% prevalence of HPV16/18 in the cervical cancer tissue samples. A way to minimise this gynaecological concern would be to introduce prophylactic vaccines and early screening in the state of Bihar. The data generated would be crucial in drafting for community screening of HPV. We strongly emphasize the prophylactic HPV Vaccination against HPV 16 to control the alarming rate of cervical cancer in one of the most populous state of India, Bihar.


Sign in / Sign up

Export Citation Format

Share Document